Rachel King, co-Founder and Chief Executive Officer of GlycoMimetics, Inc., testified today on behalf of the Biotechnology Innovation Organization (BIO) before the Joint Economic Committee. King discussed the need to build on the success of the JOBS Act, FDASIA’s “breakthrough therapies” designation, as well as policies that provide tax relief and strengthen patent protections.
{iframe}https://www.businesswire.com/news/home/20180725005525/en/Biotech-CEO-Testifies-Joint-Economic-Committee-Pro-Growth{/iframe}